Joseph P. Novak

Preclinical toxicity evaluation of JD5037, a peripherally restricted CB1 receptor inverse agonist, in rats and dogs for treatment of nonalcoholic steatohepatitis

Vijay P. Kale, Seth Gibbs, John Taylor et al. · Regulatory Toxicology and Pharmacology · 2019 · 25 citations · Full text

Medicine, Pharmacology, Toxicology +8

Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation

Matthew E. Stokes, Kerstin Wenzl, C. Chris Huang et al. · Nature Communications · 2024 · 16 citations · Full text

Medicine, Cancer Biology, Oncology +17

Molecular Clusters and Tumor-Immune Drivers of IgM Monoclonal Gammopathies

Patrizia Mondello, Jonas Paludo, Joseph P. Novak et al. · Clinical Cancer Research · 2022 · 14 citations

Medicine, Immunology, Oncology +17

Follicular lymphoma B cells exhibit heterogeneous transcriptional states with associated somatic alterations and tumor microenvironments

Jordan E. Krull, Kerstin Wenzl, Melissa A. Hopper et al. · Cell Reports Medicine · 2024 · 11 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Extramedullary myeloma is genomically complex and characterized by near-universal MAPK pathway alterations

Saurabh Zanwar, Joseph P. Novak, Wilson I. Gonsalves et al. · Blood Advances · 2025 · 11 citations · Full text

Medicine, Hematology, Oncology +16